There are many different types of uveitis, which can be difficult to treat. Each type has different clinical manifestations, progression patterns, and medications used for treatment, duration of treatment, and method of administration, and the physician needs to develop an individualized treatment plan that is appropriate for the patient. For anterior uveitis, i.e., iritis or iridocyclitis, topical hormones, nonsteroidal anti-inflammatory drugs, and pupil dilators are commonly used; for posterior uveitis, most oral medications are used depending on the type of uveitis, and for autoimmune uveitis, oral hormones and immunosuppressive agents are required. Local periocular hormone injections may also be required in special cases. There are many types of uveitis that require long-term treatment and the treatment process should not be stopped at will, as this could lead to a loss of success and worsening of the condition. Even during the course of treatment, uveitis may recur or worsen. Therefore, patients need to understand the complexity, difficulty, and long-term nature of treating this disease, have enough patience and confidence, actively cooperate with doctors, and have regular follow-ups in order to obtain better treatment results. Since traditional hormone and immunosuppressant treatment can bring more side effects to the whole body, many patients have difficulty in adhering to the treatment, resulting in the disease being prolonged, and some patients have difficulty in controlling the disease even with a large amount of medication. Novel therapies, including biologics, vitreous drugs (including hormonal extended-release drugs and rapamycin vitreous injections) and mesenchymal stem cell therapy, are expected to overcome the side effects of traditional treatments and provide new options for the treatment of uveitis.